Category Archives: Health Care

Health Care

Apollonia and Synergy Partner to Improve Oral Health for Children with Autism

Apollonia and Synergy Sign Strategic MoU with Mohammed bin Rashid Center for Special Education to Enhance Autism Care in Abu Dhabi

Abu Dhabi – May 1, 2026

In a step reflecting its leadership in advancing specialized healthcare services, the Mohammed bin Rashid Center for Special Education announced the signing of a strategic Memorandum of Understanding (MoU) with Apollonia and Synergy Dental Centers. The partnership aims to enhance oral healthcare for children with Autism Spectrum Disorder (ASD), and was formalized during a scientific conference held at Conrad Abu Dhabi Etihad Towers.

The collaboration aligns with a shared vision to build an integrated oral healthcare ecosystem based on the latest scientific practices and international standards, contributing to improving the quality of life for children of determination.

Continue reading Apollonia and Synergy Partner to Improve Oral Health for Children with Autism →
Health Care

PureHealth Reports Revenue of AED 7.3 Billion and Net Profit of AED 415 Million in Q1-2026

  • Group revenue growth of 10% year-on-year driven by strong growth across the Group’s international portfolio and the Cover vertical.
  • EBITDA increased 5% year-on-year to AED 1.2 billion.
  • The Group is well-positioned to continue pursuing value accretive growth, supported by a solid balance sheet with total assets of AED 57.3 billion.

Abu Dhabi, 1 May 2026 – PureHealth Holding PJSC (“PureHealth” or “the Group”) (ADX Symbol: PUREHEALTH), the largest healthcare group in the Middle East, today announced its financial results for the three-month period ended 31 March 2026.

Continue reading PureHealth Reports Revenue of AED 7.3 Billion and Net Profit of AED 415 Million in Q1-2026 →
Health Care

Understanding Seizure Patterns: Insights from Mayo Clinic

In a neurology lab at Mayo Clinic, Dr. Benjamin Brinkmann studies the brain’s electrical rhythms across days, weeks and months — searching for patterns that reveal when seizures are most likely to occur. Working with neuroscientists and clinicians, he combines data from brain waves, vital signs and imaging to develop tools that interpret those signals and help guide patient care.

Epilepsy is a brain disorder that causes recurring seizures — sudden bursts of electrical activity that can interrupt movement, speech or awareness. For many people living with this condition, medication keeps seizures under control. But for those with drug-resistant epilepsy, the episodes can occur without warning — disrupting routines and independence.

Continue reading Understanding Seizure Patterns: Insights from Mayo Clinic →
Health Care

Overcoming Obstacles: Parkinson’s Treatment Journey to King’s College Hospital

International Parkinson’s Patient Travels Over 18 Hours to Dubai for Advanced Treatment at King’s College Hospital London, Dubai

When Care Cannot Wait: Parkinson’s Patient Travels Across Continents to King’s College Hospital London, Dubai

Global Demand for Advanced Care Remains Strong: Parkinson’s Patient Travels 18 Hours to King’s College Hospital London, Dubai

Dubai, UAE – Parkinson’s disease does not stop for conflict, uncertainty, or distance. For people with advanced neurological conditions, timely specialist care is always needed. This was clear in the journey of a 57-year-old man who traveled to Dubai for treatment at King’s College Hospital Dubai, overcoming several disruptions along the way.

Continue reading Overcoming Obstacles: Parkinson’s Treatment Journey to King’s College Hospital →
Health Care

Oral Semaglutide Trial: Breakthrough for Type 2 Diabetes in Teens

Dubai, UAE – April 30, 2026: Novo Nordisk today announced positive topline results from PIONEER TEENS, a phase 3a trial evaluating oral semaglutide for type 2 diabetes in children and adolescents aged 10–17 years with type 2 diabetes. Oral semaglutide demonstrated a superior reduction in HbA1c (a measure of blood sugar control) over placebo in the trial and showed a well-tolerated safety profile consistent with previous Novo Nordisk semaglutide trials. Oral semaglutide is available today as Rybelsus® in the EU and US and will be available in the US as Ozempic® pill soon.

Dr. Motaz Azzam – senior pediatric endocrinology fellow – Al Jalila Children’s Hospital

Continue reading Oral Semaglutide Trial: Breakthrough for Type 2 Diabetes in Teens →